Whalesbook Logo

Whalesbook

  • Home
  • About Us
  • Contact Us
  • News

Medi Assist Healthcare Profit Drops 61.6% Amidst Acquisition and Tech Investments

Healthcare/Biotech

|

Updated on 06 Nov 2025, 07:07 am

Whalesbook Logo

Reviewed By

Akshat Lakshkar | Whalesbook News Team

Short Description :

Medi Assist Healthcare Services reported a 61.6% fall in profit to Rs. 8.1 crore for the quarter ended September 30, 2025, despite a 25.5% rise in total income. The decline was attributed to acquisition costs from Paramount TPA, higher technology spending, and increased finance costs.
Medi Assist Healthcare Profit Drops 61.6% Amidst Acquisition and Tech Investments

▶

Stocks Mentioned :

Medi Assist Healthcare Services India Limited

Detailed Coverage :

Medi Assist Healthcare Services announced a significant drop in profit for the quarter ended September 30, 2025, with earnings falling 61.6% to Rs. 8.1 crore from Rs. 21 crore in the previous year. This occurred even as total income grew by 25.5% to Rs. 232.6 crore. The company attributed the reduced profitability to transitional costs associated with its acquisition of Paramount TPA and increased investments in technology. Profit before tax from continuing operations declined by 54.3%. Total expenses surged by 40.4% to Rs. 221.4 crore, outpacing revenue growth. Finance costs saw a substantial increase, rising over fourfold to Rs. 7.6 crore, primarily due to borrowing for the Paramount deal. Employee benefits expense increased by 37.1% to Rs. 105.5 crore, while depreciation and amortisation rose by 54.6% to Rs. 20.9 crore. The company's operating margins were pressured, compressing EBITDA by approximately 250 basis points due to integration and technology costs. CEO Satish Gidugu highlighted that technology and partnerships are driving transformation in the health insurance sector. He also mentioned the completion of the Paramount acquisition, a tie-up with Star Health, expansion in international benefits administration, and investment from MIT as demonstrations of confidence in Medi Assist's vision. The company's premium under management grew 20.2% year-on-year to Rs. 12,719 crore, and its market share in health insurance premiums administered increased to 21.3%. Technology-led fraud and waste prevention initiatives generated savings of around Rs. 230 crore. Despite these positive operational developments, earnings per share (EPS) fell to Rs. 1.13 from Rs. 2.98. The near-term cost of expansion has eroded profitability.

Impact This news is significant for investors as it highlights how acquisition and expansion costs can temporarily impact profitability, even with strong revenue growth. While the long-term strategy appears sound with market share gains and savings initiatives, the immediate financial performance might lead to cautious investor sentiment and potential short-term stock price volatility. Rating: 6/10

Difficult Terms * **TPA (Third Party Administrator)**: A company that processes insurance claims and administrative tasks on behalf of insurance companies. * **EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization)**: A measure of a company's operating performance, excluding financing and accounting decisions. * **Basis Points**: A unit equal to 1/100th of 1% of a percentage point. Used to describe small changes in percentages. 250 basis points equals 2.5%. * **EPS (Earnings Per Share)**: A company's net profit divided by the number of outstanding shares, indicating profitability per share.

More from Healthcare/Biotech

Zydus Lifesciences' Beta-Thalassemia Drug Desidustat Receives USFDA Orphan Drug Designation

Healthcare/Biotech

Zydus Lifesciences' Beta-Thalassemia Drug Desidustat Receives USFDA Orphan Drug Designation

Medi Assist Healthcare Profit Drops 61.6% Amidst Acquisition and Tech Investments

Healthcare/Biotech

Medi Assist Healthcare Profit Drops 61.6% Amidst Acquisition and Tech Investments

Sun Pharma's US Innovative Drug Sales Surpass Generics for First Time

Healthcare/Biotech

Sun Pharma's US Innovative Drug Sales Surpass Generics for First Time

Indoco Remedies Posts Improved Q2 Earnings, Stock Sees Gains

Healthcare/Biotech

Indoco Remedies Posts Improved Q2 Earnings, Stock Sees Gains

Abbott India Reports 16% Profit Jump on Strong Revenue and Margins

Healthcare/Biotech

Abbott India Reports 16% Profit Jump on Strong Revenue and Margins

Zydus Lifesciences Reports 39% Profit Growth in Q2 FY26, Plans ₹5,000 Crore Fundraising

Healthcare/Biotech

Zydus Lifesciences Reports 39% Profit Growth in Q2 FY26, Plans ₹5,000 Crore Fundraising


Latest News

Sterlite Technologies Reports Profit Growth but Revenue Decline in Q2 FY26, Order Book Surges

Tech

Sterlite Technologies Reports Profit Growth but Revenue Decline in Q2 FY26, Order Book Surges

Vedanta Secures 500 MW Power Supply Pact with Tamil Nadu for Five Years

Energy

Vedanta Secures 500 MW Power Supply Pact with Tamil Nadu for Five Years

Indian Equity Markets Close Lower Amid Volatility and Profit Booking

Economy

Indian Equity Markets Close Lower Amid Volatility and Profit Booking

Cholamandalam Investment Reports 20% Profit Growth in Q2FY26 Amid Rising NPAs

Banking/Finance

Cholamandalam Investment Reports 20% Profit Growth in Q2FY26 Amid Rising NPAs

India Services Sector Growth Slows to 5-Month Low in October

Economy

India Services Sector Growth Slows to 5-Month Low in October

India's Consumer Sector Faces Sweeping Leadership Overhaul

Consumer Products

India's Consumer Sector Faces Sweeping Leadership Overhaul


Agriculture Sector

UN Deputy Secretary-General Urges Alignment of Global Food Systems with Climate Action at COP30

Agriculture

UN Deputy Secretary-General Urges Alignment of Global Food Systems with Climate Action at COP30


Media and Entertainment Sector

Hollywood Films Gain Traction in India with Horror and Drama, Shifting Away from Superheroes

Media and Entertainment

Hollywood Films Gain Traction in India with Horror and Drama, Shifting Away from Superheroes

More from Healthcare/Biotech

Zydus Lifesciences' Beta-Thalassemia Drug Desidustat Receives USFDA Orphan Drug Designation

Zydus Lifesciences' Beta-Thalassemia Drug Desidustat Receives USFDA Orphan Drug Designation

Medi Assist Healthcare Profit Drops 61.6% Amidst Acquisition and Tech Investments

Medi Assist Healthcare Profit Drops 61.6% Amidst Acquisition and Tech Investments

Sun Pharma's US Innovative Drug Sales Surpass Generics for First Time

Sun Pharma's US Innovative Drug Sales Surpass Generics for First Time

Indoco Remedies Posts Improved Q2 Earnings, Stock Sees Gains

Indoco Remedies Posts Improved Q2 Earnings, Stock Sees Gains

Abbott India Reports 16% Profit Jump on Strong Revenue and Margins

Abbott India Reports 16% Profit Jump on Strong Revenue and Margins

Zydus Lifesciences Reports 39% Profit Growth in Q2 FY26, Plans ₹5,000 Crore Fundraising

Zydus Lifesciences Reports 39% Profit Growth in Q2 FY26, Plans ₹5,000 Crore Fundraising


Latest News

Sterlite Technologies Reports Profit Growth but Revenue Decline in Q2 FY26, Order Book Surges

Sterlite Technologies Reports Profit Growth but Revenue Decline in Q2 FY26, Order Book Surges

Vedanta Secures 500 MW Power Supply Pact with Tamil Nadu for Five Years

Vedanta Secures 500 MW Power Supply Pact with Tamil Nadu for Five Years

Indian Equity Markets Close Lower Amid Volatility and Profit Booking

Indian Equity Markets Close Lower Amid Volatility and Profit Booking

Cholamandalam Investment Reports 20% Profit Growth in Q2FY26 Amid Rising NPAs

Cholamandalam Investment Reports 20% Profit Growth in Q2FY26 Amid Rising NPAs

India Services Sector Growth Slows to 5-Month Low in October

India Services Sector Growth Slows to 5-Month Low in October

India's Consumer Sector Faces Sweeping Leadership Overhaul

India's Consumer Sector Faces Sweeping Leadership Overhaul


Agriculture Sector

UN Deputy Secretary-General Urges Alignment of Global Food Systems with Climate Action at COP30

UN Deputy Secretary-General Urges Alignment of Global Food Systems with Climate Action at COP30


Media and Entertainment Sector

Hollywood Films Gain Traction in India with Horror and Drama, Shifting Away from Superheroes

Hollywood Films Gain Traction in India with Horror and Drama, Shifting Away from Superheroes